340
Views
31
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Protective effect of sesamol against 60Co γ-ray-induced hematopoietic and gastrointestinal injury in C57BL/6 male mice

, , , &
Pages 1344-1361 | Received 30 Apr 2015, Accepted 06 Jul 2015, Published online: 12 Aug 2015

References

  • Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003;4:529–536.
  • Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, et al. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 2004;140:1037–1051.
  • Hendry JH, Feng-Tong Y. Response of bone marrow to low LET irradiation. Radiation Toxicology: Bone Marrow and Leukaemia. London: Taylor & Francis; 1995. pp. 91–116.
  • Fliedner T, Nothdurft W, Heit H. Biological factors affecting the occurrence of radiation syndromes. Response of Different Species to Total Body Irradiation. Springer; 1984. pp. 209–219.
  • Singh VK, Ducey EJ, Brown DS, Whitnall MH. A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute. Int J Radiat Biol 2012;88:296–310.
  • Culy CR, Spencer CM. Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome. Drugs 2001;61: 641–684.
  • Weiss JF. Pharmacologic approaches to protection against radiation-induced lethality and other damage. Environ Health Perspect 1997;105:1473–1478.
  • Kumar KS, Srinivasan V, Toles R, Jobe L, Seed TM. Nutritional approaches to radioprotection: vitamin E. Mil Med 2002;167:57–59.
  • Seed TM. Radiation protectants: current status and future prospects. Health Phys 2005;89:531–545.
  • Pellmar TC, Rockwell S. Radiological/Nuclear Threat Countermeasures Working G. Priority list of research areas for radiological nuclear threat countermeasures. Radiat Res 2005;163:115–123.
  • Ando K, Sako K, Takahashi M, Beppu M, Kikugawa K. Increased band 3 protein aggregation and anti-band 3 binding of erythrocyte membranes on treatment with sesamol. Biol Pharm Bull 2000;23:159–164.
  • Sharma S, Kaur IP. Development and evaluation of sesamol as an antiaging agent. Int J Dermatol 2006;45:200–208.
  • Kapadia GJ, Azuine MA, Tokuda H, Takasaki M, Mukainaka T, Konoshima T, Nishino H. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol Res 2002;45:499–505.
  • Hsu DZ, Chen KT, Li YH, Chuang YC, Liu MY. Sesamol delays mortality and attenuates hepatic injury after cecal ligation and puncture in rats: role of oxidative stress. Shock 2006;25:528–532.
  • Joshi R, Kumar MS, Satyamoorthy K, Unnikrisnan MK, Mukherjee T. Free radical reactions and antioxidant activities of sesamol: pulse radiolytic and biochemical studies. J Agric Food Chem 2005;53:2696–2703.
  • Prasad NR, Menon VP, Vasudev V, Pugalendi KV. Radioprotective effect of sesamol on gamma-radiation induced DNA damage, lipid peroxidation and antioxidants levels in cultured human lymphocytes. Toxicol 2005;209:225–235.
  • Nair GG, Nair CK. Protection of cellular DNA and membrane from gamma-radiation-induced damages and enhancement in DNA repair by sesamol. Cancer Biother Radiopharm 2010;25:629–635.
  • Parihar VK, Prabhakar KR, Veerapur VP, Kumar MS, Reddy YR, Joshi R, et al. Effect of sesamol on radiation- induced cytotoxicity in Swiss albino mice. Mutat Res 2006;611:9–16.
  • Kanimozhi P, Prasad NR. Antioxidant potential of sesamol and its role on radiation-induced DNA damage in whole-body irradiated Swiss albino mice. Environ Toxicol Pharmacol 2009;28:192–197.
  • Mishra K, Ojha H, Chaudhury NK. Estimation of antiradical properties of antioxidants using DPPH assay: A critical review and results. Food Chem 2012;130:1036–1043.
  • Mishra K, Srivastava PS, Chaudhury NK. Sesamol as a potential radioprotective agent: in vitro studies. Radiat Res 2011;176:613–623.
  • Williams JP, Brown SL, Georges GE, Hauer-Jensen M, Hill RP, Huser AK, et al. Animal models for medical countermeasures to radiation exposure. Radiat Res 2010;173:557–578.
  • Lindsay KJ, Coates PJ, Lorimore SA, Wright EG. The genetic basis of tissue responses to ionizing radiation. Br J Radiol 2007;80 Spec No 1:S2–6.
  • Iwata M, Iwakawa M, Noda S, Ohta T, Minfu Y, Kimura T, et al. Correlation between single nucleotide polymorphisms and jejunal crypt cell apoptosis after whole body irradiation. Int J Radiat Biol 2007;83:181–186.
  • Schmid W. The micronucleus test. Mutat Res 1975;31:9–15.
  • Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994;171:131–137.
  • Owens WE, Berg RD. Bacterial translocation from the gastrointestinal tract of athymic (nu/nu) mice. Infect Immun 1980;27:461–467.
  • Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
  • Katalinic V, Modun D, Music I, Boban M. Gender differences in antioxidant capacity of rat tissues determined by 2,2′-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays. Comp Biochem Physiol C Toxicol Pharmacol 2005;140:47–52.
  • Potten CS. A comprehensive study of the radiobiological response of the murine (BDF1) small intestine. Int J Radiat Biol 1990;58:925–973.
  • Fei P, El-Deiry WS. P53 and radiation responses. Oncogene 2003;22:5774–5783.
  • Broerse JJ, Macvittie TJ (eds). Response of Different Species to Total Body Irradiation., Netherlands: Springer; 1984.
  • Dainiak N, Waselenko JK, Armitage JO, MacVittie TJ, Farese AM. The hematologist and radiation casualties. Hematology Am Soc Hematol Educ Program 2003;473–496.
  • Booth D, Potten CS. Protection against mucosal injury by growth factors and cytokines. J Natl Cancer Inst Monogr 2001:16–20.
  • MacVittie TJ, Farese AM. Cytokine-based treatment of radiation injury: potential benefits after low-level radiation exposure. Mil Med 2002;167:68–70.
  • Vose JM, Armitage JO. Clinical applications of hematopoietic growth factors. J Clin Oncol 1995;13:1023–1035.
  • Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, et al. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 2000;18:3558–3585.
  • Luo-Owen X, Pecaut MJ, Rizvi A, Gridley DS. Low-dose total-body gamma irradiation modulates immune response to acute proton radiation. Radiat Res 2012;177:251–264.
  • Takahashi A, Ohnishi K, Asakawa I, Kondo N, Nakagawa H, Yonezawa M, et al. Radiation response of apoptosis in C57BL/6 N mouse spleen after whole-body irradiation. Int J Radiat Biol 2001;77:939–945.
  • Jang SS, Kim WD, Park WY. Melatonin exerts differential actions on X-ray radiation-induced apoptosis in normal mice splenocytes and Jurkat leukemia cells. J Pineal Res 2009;47:147–155.
  • Potten CS, Merritt A, Hickman J, Hall P, Faranda A. Characterization of radiation-induced apoptosis in the small intestine and its biological implications. Int J Radiat Biol 1994;65:71–78.
  • Potten CS, Grant HK. The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine. Br J Cancer 1998;78:993–1003.
  • Miholic J, Vogelsang H, Schlappack O, Kletter K, Szepesi T, Moeschl P. Small bowel function after surgery for chronic radiation enteritis. Digestion 1989;42:30–38.
  • Nakazawa T, Nagatsuka S. Radiation-induced lipid peroxidation and membrane permeability in liposomes. Int J Radiat Biol Relat Stud Phys Chem Med 1980;38:537–544.
  • Hovdenak N, Fajardo LF, Hauer-Jensen M. Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2000;48: 1111–1117.
  • Buell MG, Harding RK. Proinflammatory effects of local abdominal irradiation on rat gastrointestinal tract. Dig Dis Sci 1989;34:390–399.
  • Weiss JF, Landauer MR, Gunter-Smith PJ, Hanson WR. Effect of radioprotective agents on survival after acute intestinal radiation injury. Radiation and the Gastrointestinal Tract 1995;183–199.
  • Cai WB, Roberts SA, Potten CS. The number of clonogenic cells in crypts in three regions of murine large intestine. Int J Radiat Biol 1997;71:573–579.
  • Basu A, Haldar S. The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod 1998;4:1099–1109.
  • Verheij M, Bartelink H. Radiation-induced apoptosis. Cell Tissue Res 2000;301:133–142.
  • Brook I, Elliott TB, Ledney GD, Shoemaker MO, Knudson GB. Management of postirradiation infection: lessons learned from animal models. Mil Med 2004;169:194–197.
  • Guzman-Stein G, Bonsack M, Liberty J, Delaney JP. Abdominal radiation causes bacterial translocation. J Surg Res 1989;46:104–107.
  • Madonna GS, Ledney GD, Elliott TB, Brook I, Ulrich JT, Myers KR, et al. Trehalose dimycolate enhances resistance to infection in neutropenic animals. Infect Immun 1989;57: 2495–2501.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.